COR-001

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COR-001, covering 2021-07-30 to 2021-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001 [Phase 1, Phase 2]

See pricing